VERKAZIA

This brand name is authorized in Austria, Canada, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, UK.

Active ingredients

The drug VERKAZIA contains one active pharmaceutical ingredient (API):

1	Ciclosporin UNII 83HN0GTJ6D - CYCLOSPORINE
	Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect.
	Read more about Ciclosporin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VERKAZIA Eye drops, emulsion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01XA18	Ciclosporin	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02484137
EE	Ravimiamet	1775279, 1775280, 1775291, 1775303
FR	Base de données publique des médicaments	66421434
GB	Medicines & Healthcare Products Regulatory Agency	358404
IT	Agenzia del Farmaco	046918013, 046918025, 046918037, 046918049, 046918052
LT	Valstybinė vaistų kontrolės tarnyba	1085925, 1085926, 1085927, 1085928
PL	Rejestru Produktów Leczniczych	100416795